Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series-Reference-Cited by-同舟云学术

Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series

Published:2018-09 Issue:9 Volume:3 Page:635-643
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Domingo Enric,Camps Carme,Kaisaki Pamela J,Parsons Marie J,Mouradov Dmitri,Pentony Melissa M,Makino Seiko,Palmieri Michelle,Ward Robyn L,Hawkins Nicholas J,Gibbs Peter,Askautrud Hanne,Oukrif Dahmane,Wang Haitao,Wood Joe,Tomlinson Evie,Bark Yasmine,Kaur Kulvinder,Johnstone Elaine C,Palles Claire,Church David N,Novelli Marco,Danielsen Havard E,Sherlock Jon,Kerr David,Kerr Rachel,Sieber Oliver,Taylor Jenny C,Tomlinson Ian

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference28 articles.

1. The consensus molecular subtypes of colorectal cancer;Guinney;Nat Med,2015

2. Microsatellite instability in colorectal cancer;Boland;Gastroenterology,2010

3. Systematic review of microsatellite instability and colorectal cancer prognosis;Popat;J Clin Oncol,2005

4. Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study;Domingo;Lancet Gastroenterol Hepatol,2016

5. Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies;Venderbosch;Clin Cancer Res,2014

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the Interplay of KRAS, NRAS, BRAF, and Micro-Satellite Instability in Non-Metastatic Colon Cancer: A Systematic Review;Diagnostics;2024-05-12

2. Protein prognostic biomarkers in stage II colorectal cancer: implications for post-operative management;BJC Reports;2024-02-13

3. HER2 expression and genOmic characterization of rESected brain metastases from colorectal cancer: the HEROES study;British Journal of Cancer;2024-02-12

4. GNAS mutation inhibits growth and induces phosphodiesterase 4D expression in colorectal cancer cell lines;International Journal of Cancer;2024-02-06

5. Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II–III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis;The Lancet Oncology;2024-02